专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US4528188A Polysaccharide PS-A obtained from barrenwort deriving from plants belonging to the genus Epimedium, process for preparation thereof and phylactic and immunostimulating agents comprising said polysaccharide PS-A effective component 失效
公开(公告)号：US4528188A
公开(公告)日：1985-07-09
申请号：US456027
申请日：1982-12-30
申请人： Susumu Mitsuhashi , Muneaki Takase , Sosuke Yasui , Ichiro Washizawa , Kimitomo Yoshioka
发明人： Susumu Mitsuhashi , Muneaki Takase , Sosuke Yasui , Ichiro Washizawa , Kimitomo Yoshioka
IPC分类号： A61K31/715 , A61K36/00 , A61K36/296 , C08B37/00 , C12P19/04
CPC分类号： A61K36/296 , A61K31/715
摘要： A polysaccharide PS-A obtained from plants belonging to the genus Epimedium and having the following physicochemical properties, a process for preparation thereof and use as phylactic and immunostimulating agents comprising the polysaccharide PS-A as an effective component:1. Elementary analysis: C=40.92; H=6.17; Ash=very small;2. Molecular weight: 75,000.+-.25,000 (average molecular weight);3. Decomposition point: 205.degree. C.;4. pH: 7.0 (solution of 100 mg of PS-A in 50 ml of water);5. Specific rotatory power: [.alpha.].sub.D.sup.19 =-23.6.degree. (in H.sub.2 O, c=0.527);6. Infrared absorption spectrum: .nu..sub.max.sup.KBr (cm.sup.-1)/3400, 2900, 1620, 1400, 1230, 1060;7. Ultraviolet absorption spectrum: Maximum absorption is not recognized in the range of 240-400 nm.;8. Outward form: White or faint brown, amorphous powder;9. Solubility:(a) Soluble in water;(b) Insoluble in methanol, ethanol, acetone, ethyl acetate, diethyl ether, hexane and chloroform;10. Color reactions:Positive to the following reactions: (a) anthrone-sulfuric acid reaction; (b) Molisch's reaction; (c) skatol reaction; and (d) Bial's reaction;Negative to the following reactions: (a) ninhydrin reaction; (b) 2,4-DNP reaction; (c) Selivanoff's reaction; (d) naphthoresorcinol reaction; and (e) carbazol-sulfuric acid reaction;11. Component sugars: Arabinose and galactose;12. Homogeneity: Homogeneity is proved according to ultracentrifugation, electrophoresis and gel filtration.

2. 发明授权

US4501736A Extract from barrenwort 失效
标题翻译：从小麦提取物
公开(公告)号：US4501736A
公开(公告)日：1985-02-26
申请号：US520760
申请日：1983-08-08
申请人： Susumu Mitsuhashi , Muneaki Takase , Sosuke Yasui , Ichiro Washizawa , Kimitomo Yoshioka
发明人： Susumu Mitsuhashi , Muneaki Takase , Sosuke Yasui , Ichiro Washizawa , Kimitomo Yoshioka
IPC分类号： A61K36/296 , A61K39/39 , A61K35/78
CPC分类号： A61K39/39 , A61K36/296 , A61K2039/55588
摘要： The present invention provides an extract obtained by extracting a plant belonging to the genus Epimedium sp. with a mixed solvent of water and a water-miscible organic solvent or with water, defatting the obtained aqueous extract and collecting a high-molecular compounds-containing fraction from the defatted aqueous extract, a process for preparation of this extract, an antibacterial agent comprising this extract as an effective component and an antibacterial therapy by using this extract.
摘要翻译：本发明提供通过提取属于淫羊藿属属植物的植物而获得的提取物。与水和水混溶性有机溶剂的混合溶剂或与水混合，使得到的水提取物脱脂并从脱脂水提取物中收集含高分子化合物的级分，该提取物的制备方法，包含该提取物作为有效成分，通过使用该提取物进行抗菌治疗。

3. 发明授权

US5290691A Safe and versatile cloning vector 失效
标题翻译：安全多功能的克隆载体
公开(公告)号：US5290691A
公开(公告)日：1994-03-01
申请号：US814203
申请日：1991-12-26
申请人： Susumu Mitsuhashi , Matsuhisa Inoue , Masao Nagashima
发明人： Susumu Mitsuhashi , Matsuhisa Inoue , Masao Nagashima
IPC分类号： C12N15/75 , C12N15/78 , C12N15/00 , C12N15/11 , C12N15/70 , C12N15/74
CPC分类号： C12N15/75 , C12N15/78
摘要： A safe and versatile recombinant DNA cloning vector having at least two functionally different replication origins selected independently from the group consisting of a replication origin functional in Bacillus subtilis, a replication origin functional in Escherichia coli and a replication origin functional in Pseudomonas aeruginosa, and at least one DNA segment which provides resistance against at least one antibiotic after introduction into susceptible host cells. The origin for replication origin functional in Bacillus subtilis can be a restriction fragment of a plasmid of Gram positive bacteria, and that Escherichia coli or Pseudomonas aeruginosa can be a restriction fragment of a plasmid of Gram negative bacteria, e.g. a restriction fragment of plasmids pMS 140-1 or pMS 71.
摘要翻译：一种安全且通用的重组DNA克隆载体，其具有至少两个功能上不同的复制起点，其独立地选自在枯草芽孢杆菌中起作用的复制起点，在大肠杆菌中起作用的复制起点和在铜绿假单胞菌中起作用的复制起点，以及至少一个DNA片段，其在引入易感宿主细胞后提供对至少一种抗生素的抗性。在枯草芽孢杆菌中起作用的复制起点可以是革兰氏阳性细菌质粒的限制性片段，并且大肠杆菌或铜绿假单胞菌可以是革兰氏阴性细菌质粒的限制性片段，例如，质粒pMS 140-1或pMS 71的限制性片段。

4. 发明授权

US4199566A Antibacterial composition for medical use 失效
标题翻译：用于医疗用途的抗菌组合物
公开(公告)号：US4199566A
公开(公告)日：1980-04-22
申请号：US913105
申请日：1978-06-06
申请人： Isamu Saikawa , Takashi Yasuda , Masaru Tai , Yutaka Takashita , Hiroshi Sakai , Michiko Mae , Masahiro Takahata , Susumu Mitsuhashi
发明人： Isamu Saikawa , Takashi Yasuda , Masaru Tai , Yutaka Takashita , Hiroshi Sakai , Michiko Mae , Masahiro Takahata , Susumu Mitsuhashi
IPC分类号： C07D499/68 , A61K31/43 , A61K31/545 , A61P31/04 , C07D499/64 , A61K35/00
CPC分类号： A61K31/43 , A61K31/545
摘要： An antibacterial composition for medical use comprising 6-[-)-.alpha.-(4-ethyl-2,3-dioxo-1-piperazinylcarbonylamino)phenylacetamido]penicillanic acid or a pharmaceutically acceptable salt thereof and a .beta.-lactamase-inhibiting penicillin or cephalosporin. The composition exhibits synergistic effect which is much greater than the sum of antibacterial effects of each component used alone.
摘要翻译：一种用于医疗用途的抗菌组合物，其包含6 - [ - ） - α-（4-乙基-2,3-二氧代-1-哌嗪基羰基氨基）苯乙酰胺基]青霉烷酸或其药学上可接受的盐和β-内酰胺酶抑制青霉素或头孢菌素组合物显示出比单独使用的每种组分的抗菌作用的总和大得多的协同效应。

5. 发明授权

US4428936A Antibacterial composition for medical use 失效
标题翻译：用于医疗用途的抗菌组合物
公开(公告)号：US4428936A
公开(公告)日：1984-01-31
申请号：US187755
申请日：1980-09-16
申请人： Isamu Saikawa , Takashi Yasuda , Masaru Tai , Yutaka Takashita , Hiroshi Sakai , Michiko Mae , Masahiro Takahata , Susumu Mitsuhashi
发明人： Isamu Saikawa , Takashi Yasuda , Masaru Tai , Yutaka Takashita , Hiroshi Sakai , Michiko Mae , Masahiro Takahata , Susumu Mitsuhashi
IPC分类号： C07D501/34 , A61K31/545 , A61K31/546 , C07D501/36 , A61K35/00
CPC分类号： A61K31/545
摘要： An antibacterial composition for medical use comprising a cephalosporin or a pharmaceutically acceptable salt thereof and a .beta.-lactamase-inhibiting compound having a .beta.-lactam ring. The composition exhibits synergistic effect which is much greater than the sum of antibacterial effects of each component used alone.
摘要翻译：一种用于医疗用途的抗菌组合物，其包含头孢菌素或其药学上可接受的盐和具有β-内酰胺环的β-内酰胺酶抑制化合物。组合物显示出比单独使用的每种组分的抗菌作用的总和大得多的协同效应。

6. 发明授权

US4324783A Antibacterial composition for medical use 失效
标题翻译：用于医疗用途的抗菌组合物
公开(公告)号：US4324783A
公开(公告)日：1982-04-13
申请号：US113065
申请日：1980-01-17
申请人： Isamu Saikawa , Takashi Yasuda , Masaru Tai , Yutaka Takashita , Hiroshi Sakai , Michiko Mae , Masahiro Takahata , Susumu Mitsuhashi
发明人： Isamu Saikawa , Takashi Yasuda , Masaru Tai , Yutaka Takashita , Hiroshi Sakai , Michiko Mae , Masahiro Takahata , Susumu Mitsuhashi
IPC分类号： C07D499/68 , A61K31/43 , A61K31/545 , A61P31/04 , C07D499/64 , A61K35/00
CPC分类号： A61K31/43 , A61K31/545
摘要： An antibacterial composition for medical use comprising 6-[D(-)-.alpha.-(4-ethyl-2,3-dioxo-1-piperazinylcarbonylamino)phenylacetamido]penicillanic acid or a pharmaceutically acceptable salt thereof and a .beta.-lactamase-inhibiting penicillin or cephalosporin. The composition exhibits synergistic effect which is much greater than the sum of antibacterial effects of each component used alone.
摘要翻译：一种用于医疗用途的抗菌组合物，其包含6- [D（ - ） - α-（4-乙基-2,3-二氧代-1-哌嗪基羰基氨基）苯基乙酰胺基]青霉烷酸或其药学上可接受的盐和β-内酰胺酶抑制青霉素或头孢菌素。组合物显示出比单独使用的每种组分的抗菌作用的总和大得多的协同效应。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式